When comparing BC-PDMs and primary tumor profiles, we found decreased expression of NFkB signaling pathway proteins NFkB regulates processes of immune and inflammatory responses and is part of the immune defense against transformed cells [108, 109]. The gene discussed is NFKB1; the disease is breast cancer.